Skip to main content
Caplight Logo









Dioseve Inc.

Dioseve Inc.

Private
TokyoHealthcare & Life Scienceshttps://dioseve.com/

Last Round

Series A

Extension

Jun 16, 2026

Total Funding Raised

$17M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Dioseve Inc. is a biotechnology company that develops assisted reproductive technology using oocytes and ovarian somatic cells derived from induced pluripotent stem (iPS) cells.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

iPS cell technologyregenerative medicineinduced pluripotent stem cellsiPSCassisted reproductive technologyARTinfertility treatmentoocyte developmentIVF innovationreproductive biotechnologylab-grown eggsstem cell therapyreproductive healthclinical researchbiotech R&D

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Dioseve Inc. Comparables

Compare Dioseve Inc. with similar companies based on industry and business-model similarity.

Dioseve Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Conception
87%
Ivy Natal
86%
Vitra Labs
84%

Dioseve Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionJun 16, 2026
Series AJun 27, 2024
SeedAug 18, 2022

Key People

Founding team and executive leadership

Kaz Kishida

Chief Executive Officer

Executive Team

Dioseve Inc. Investors

Notable investors and investment history

Dioseve Inc. investors
InvestorRounds
Coral CapitalSeed
Shionogi & Co.Series A Extension
D4V (Design for Ventures)Series A Extension
Hokuriku Region Venture FundSeries A
DG Daiwa VenturesSeries A Extension, Series A
ANRI株式会社Series A, Seed
MiraidoaSeries A Extension, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 17, 2026

    Led by Shionogi & Co.

  • Apr 1, 2026

    Assisted reproductive technology using iPS cells has entered the clinical research phase.

Recent news

Latest coverage and updates

  • receives_financingJun 16, 2026

    Dioseve, Inc. received financing of $6.22M in Series A on Jun 17th '26.

Dioseve Inc. Filings

Explore SEC and related filing metadata, where available.

Dioseve Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Dioseve Inc.'s valuation, stock price, and market status.

Is Dioseve Inc. a public or private company?

Dioseve Inc. is a private company.

What is the current stock price of Dioseve Inc.?

Dioseve Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is Dioseve Inc. worth (valuation)?

Valuation information for Dioseve Inc. is not publicly available.

Can I buy Dioseve Inc. stock?

Dioseve Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Dioseve Inc.'s last funding round?

Dioseve Inc.'s most recent funding round was Series A Extension on June 17, 2026.

Who are the main investors in Dioseve Inc.?

Key investors in Dioseve Inc. include Shionogi & Co., ANRI株式会社, Spiral Capital, Archetype Ventures.

Will Dioseve Inc. IPO soon?

No public IPO plans have been announced for Dioseve Inc..

How can I track Dioseve Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Dioseve Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersTokyo
Employee Range6
Year Founded2021
Last FundingJun 16, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?